¼¼°èÀÇ ¾Ï Ä¡·á ½Ã¼³ ½ÃÀå º¸°í¼­(2025³â)
Cancer Treatment Facilities Global Market Report 2025
»óǰÄÚµå : 1810846
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,294,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,098,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,902,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Ï Ä¡·á ½Ã¼³ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 7.9%·Î 654¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº ÀÇ·á º¸Çè¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë, ¸ÂÃãÇü Ä¡·á Á¢±Ù¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¾Ï Ä¡·á¸¦ À§ÇÑ ÀÇ·á °ü±¤ÀÇ ¼ºÀå, ¾Ï ¿¬±¸ ¹× ½Ã¼³ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, AI ¹× µðÁöÅÐ Çコ ±â¼ú ÅëÇÕÀÇ È®´ë¿¡ ÀÇÇØ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¹æ»ç¼± Ä¡·áÀÇ Çõ½Å, Á¾¾çÇп¡¼­ÀÇ ÀΰøÁö´É Ȱ¿ë, ·Îº¿ º¸Á¶ ¼ö¼ú ½Ã½ºÅÛ µµÀÔ, ¸ÂÃãÇü ÀÇ·á¿Í À¯Àüü ÀÇÇÐÀÇ ¹ßÀü, ¿µ»ó Áø´Ü ¹× Áø´Ü ±â¼úÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù.

¾Ï À¯º´·üÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ¾Ï Ä¡·á ½Ã¼³ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾ÏÀº ü³» ºñÁ¤»óÀûÀÎ ¼¼Æ÷ÀÇ ÅëÁ¦ÇÒ ¼ö ¾ø´Â Áõ½Ä°ú È®»êÀÌ Æ¯Â¡ÀÎ Áúº´±ºÀÔ´Ï´Ù. ¾Ï ¹ßº´ À§ÇèÀº ³ªÀ̰¡ µé¾î°¨¿¡ µû¶ó Å©°Ô Áõ°¡Çϱ⠶§¹®¿¡ ¾Ï ȯÀÚ Áõ°¡´Â Àα¸ °í·ÉÈ­¿¡ ±âÀÎÇÏ´Â ¹Ù°¡ Å®´Ï´Ù. ¾Ï Ä¡·á ½Ã¼³Àº Á¶±â Áø´Ü, °í±Þ Ä¡·á ¿É¼Ç, Áö¼ÓÀûÀÎ Ä¡·á¸¦ Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ Áõ°¡ÇÏ´Â ºÎ´ãÀ» °ü¸®ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 2¿ù È£ÁÖ¿¡ º»ºÎ¸¦ µÐ ºñ¿µ¸®´ÜüÀÎ Leukaemia FoundationÀº 2022³âºÎÅÍ 2035³â±îÁö 7,000¸í ÀÌ»óÀÇ ¾î¸°ÀÌ, 6,000¸í ÀÌ»óÀÇ ÀþÀº ¼ºÀÎ, 108,000¸í ÀÌ»óÀÇ 25-65¼¼ ¼ºÀÎÀÌ ±Þ¼º ¸²ÇÁ¾Æ±¸¼º ¹éÇ÷º´(ALL), ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´(AML), ºñÈ£ÁöŲ¸²ÇÁÁ¾(Non-Hodgkin lymphoma) µîÀÇ Ç÷¾×¾Ï Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ALL), ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´(AML), ºñÈ£ÁöŲ¸²ÇÁÁ¾ µî Ç÷¾×¾Ï Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµÈ´Ù°í º¸°íÇß½À´Ï´Ù. ±× °á°ú, ¾Ï ¹ßº´·üÀÇ Áõ°¡´Â ¾Ï Ä¡·á ½Ã¼³ ½ÃÀåÀÇ È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

¾Ï Ä¡·á ½Ã¼³ ½ÃÀåÀÇ ±â¾÷µéÀº ¾Ï Ä¡·áÀÇ Á¤È®µµ¸¦ ³ôÀ̱â À§ÇØ ÀüÀÚºö Ä¡·á¿Í °°Àº ÷´Ü ±â¼ú¿¡ Á¡Á¡ ´õ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ¼± Ä¡·á´Â °í¿¡³ÊÁö ÀüÀÚ¸¦ ÀÌ¿ëÇÏ¿© üǥ ºÎ±Ù¿¡ ÀÖ´Â ¾ÏÀ» Ä¡·áÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 10¿ù ¾Æ¶ø¿¡¹Ì¸®Æ®¿¡ º»»ç¸¦ µÐ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÎ Astor DM Healthcare´Â ¾Ï Ä¡·á¸¦ À§ÇØ ¼ö¼ú Áß ÀüÀÚ¼± Ä¡·á(IOeRT)¸¦ µµÀÔÇß½À´Ï´Ù. ÀÌ ¹æ¹ýÀº ¼ö¼ú Áß Á¾¾çÃþ¿¡ Á÷Á¢ °í¼±·®ÀÇ ÀüÀÚºöÀ» ÁýÁß Á¶»çÇÏ´Â °ÍÀ¸·Î, Á÷Á¢ °¡½ÃÈ­ÇÒ ¼ö ÀÖ´Â ÀåÁ¡À» »ì·Á ÀαÙÀÇ °Ç°­ÇÑ Á¶Á÷À» Â÷ÆóÇϸ鼭 ³²¾ÆÀÖ´Â ¾Ï¼¼Æ÷¸¦ Á¤È®ÇÏ°Ô Á¶ÁØÇÏ¿© ¾Ï¼¼Æ÷¸¦ Á¦°ÅÇÕ´Ï´Ù. º¸Åë 4-12MeVÀÇ °í¿¡³ÊÁö ÀüÀÚ¼±À» »ç¿ëÇϱ⠶§¹®¿¡ ¹æ»ç¼±·®ÀÌ ±Þ°ÝÈ÷ °¨¼ÒÇÏ¿© ½ÉºÎ Á¶Á÷¿¡ ´ëÇÑ ÇÇÆøÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cancer treatment facilities are specialized healthcare centers dedicated to providing comprehensive care to individuals diagnosed with cancer. These facilities employ advanced medical technologies, skilled healthcare professionals, and evidence-based treatment approaches to effectively diagnose, manage, and treat cancer, with the goal of enhancing patient outcomes and overall quality of life.

The primary types of cancer treatment facilities include those focused on blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, colorectal cancer, lung cancer, and other forms of cancer. Blood cancer originates in the blood or bone marrow and disrupts the normal development and function of blood cells. These facilities support a range of treatment modalities, such as surgical oncology, chemotherapy, radiation therapy, immunotherapy, and bone marrow transplantation. Services are provided by various healthcare entities, including hospitals and specialized cancer centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cancer treatment facilities market research report is one of a series of new reports from The Business Research Company that provides cancer treatment facilities market statistics, including cancer treatment facilities industry global market size, regional shares, competitors with a cancer treatment facilities market share, cancer treatment facilities market segments, market trends and opportunities, and any further data you may need to thrive in the cancer treatment facilities industry. This cancer treatment facilities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer treatment facilities market size has grown strongly in recent years. It will grow from $44.63 billion in 2024 to $48.27 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period was driven by a rising incidence of cancer, an expanding elderly population, greater awareness and early detection efforts, increased adoption of advanced treatment modalities, and higher overall healthcare spending.

The cancer treatment facilities market size is expected to see strong growth in the next few years. It will grow to 65.44 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The expected growth during the forecast period is fueled by expanded access to health insurance, rising demand for personalized treatment approaches, growth in medical tourism for cancer care, increased investments in cancer research and facility development, and greater integration of AI and digital health technologies. Key trends anticipated include innovations in radiation therapy, the use of artificial intelligence in oncology, adoption of robotic-assisted surgical systems, progress in personalized and genomic medicine, and advancements in imaging and diagnostic technologies.

The increasing prevalence of cancer is expected to drive the growth of the cancer treatment facilities market in the coming years. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells within the body. This rise in cancer cases is largely attributed to the aging population, as the risk of developing cancer increases significantly with age. Cancer treatment facilities play a crucial role in managing this growing burden by offering early diagnosis, advanced treatment options, and ongoing care, all of which contribute to better patient outcomes and improved quality of life. For example, in February 2023, the Leukaemia Foundation, an Australia-based non-profit organization, reported that between 2022 and 2035, over 7,000 children, 6,000 young adults, and 108,000 adults aged 25 to 65 are expected to be diagnosed with blood cancers such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin lymphoma. As a result, the rising cancer incidence is fueling the expansion of the cancer treatment facilities market.

Companies in the cancer treatment facilities market are increasingly focused on advanced technologies like electron beam therapy to improve precision in cancer care. Electron beam therapy utilizes high-energy electrons to treat cancers located near the body's surface. For instance, in October 2024, Aster DM Healthcare Limited, a UAE-based healthcare provider, introduced intraoperative electron radiation therapy (IOeRT) for cancer treatment. This method delivers a concentrated, high-dose electron beam directly to the tumor bed during surgery, taking advantage of direct visualization to accurately target any remaining cancer cells while shielding nearby healthy tissues. The use of high-energy electrons, typically ranging from 4 to 12 MeV, allows for a sharp drop-off in radiation dose, thereby minimizing exposure to deeper tissues.

In December 2024, Reliance Industries Limited, an India-based conglomerate, acquired Karkinos Healthcare for $44 million. The acquisition is part of Reliance's strategy to strengthen its role in the digital healthcare sector and improve access to advanced oncology services across India. Karkinos Healthcare is an Indian company specializing in cancer care technologies and treatment facilities.

Major players in the cancer treatment facilities market are Kaiser Permanente, HCA Healthcare Inc., CommonSpirit Health, Ascension Health, Trinity Health Corporation, Tenet Healthcare Corporation, Adventist Health System Sunbelt Healthcare Corporation, Universal Health Services Inc., Community Health Systems Inc., Ramsay Health Care Limited, Sutter Health, Stanford Health Care, Netcare Limited, Allegheny Health Network, IHH Healthcare Berhad, Fortis Healthcare, LifePoint Health Inc., Aster DM Healthcare Limited, Prime Healthcare Services Inc., and Providence Health & Services.

Asia-Pacific was the largest region in the cancer treatment facilities market in 2024, and it is expected to be the fastest-growing region in the forecast period. The regions covered in cancer treatment facilities report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cancer treatment facilities market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer treatment facilities market includes revenues earned by entities by providing services such as imaging, chemotherapy administration, tumor removal surgeries, pain management, and physical therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Treatment Facilities Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer treatment facilities market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cancer treatment facilities ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer treatment facilities market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cancer Treatment Facilities Market Characteristics

3. Cancer Treatment Facilities Market Trends And Strategies

4. Cancer Treatment Facilities Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cancer Treatment Facilities Growth Analysis And Strategic Analysis Framework

6. Cancer Treatment Facilities Market Segmentation

7. Cancer Treatment Facilities Market Regional And Country Analysis

8. Asia-Pacific Cancer Treatment Facilities Market

9. China Cancer Treatment Facilities Market

10. India Cancer Treatment Facilities Market

11. Japan Cancer Treatment Facilities Market

12. Australia Cancer Treatment Facilities Market

13. Indonesia Cancer Treatment Facilities Market

14. South Korea Cancer Treatment Facilities Market

15. Western Europe Cancer Treatment Facilities Market

16. UK Cancer Treatment Facilities Market

17. Germany Cancer Treatment Facilities Market

18. France Cancer Treatment Facilities Market

19. Italy Cancer Treatment Facilities Market

20. Spain Cancer Treatment Facilities Market

21. Eastern Europe Cancer Treatment Facilities Market

22. Russia Cancer Treatment Facilities Market

23. North America Cancer Treatment Facilities Market

24. USA Cancer Treatment Facilities Market

25. Canada Cancer Treatment Facilities Market

26. South America Cancer Treatment Facilities Market

27. Brazil Cancer Treatment Facilities Market

28. Middle East Cancer Treatment Facilities Market

29. Africa Cancer Treatment Facilities Market

30. Cancer Treatment Facilities Market Competitive Landscape And Company Profiles

31. Cancer Treatment Facilities Market Other Major And Innovative Companies

32. Global Cancer Treatment Facilities Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Treatment Facilities Market

34. Recent Developments In The Cancer Treatment Facilities Market

35. Cancer Treatment Facilities Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â